The Patent Finder

Methods and Compositions for Modulating Apolipoprotein (A) Expression

Ionis Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application PCT/US2013/042532, filed May 23, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,574,193Methods and Compositions for Modulating Apolipoprotein (A) Expression
In force
 · Medium confidence
UsedRemaining
Ionis Pharmaceuticals, Inc.In forceMedium confidence
US 9,884,072Methods and Compositions for Modulating Apolipoprotein (A) Expression
In force
 · Medium confidence
Ionis Pharmaceuticals, Inc.In forceMedium confidence
US 10,174,318Antisense Oligonucleotide Compositions
In force
 · High confidence
Ionis Pharmaceuticals, Inc.In forceHigh confidence
US 10,478,448Methods and Compositions for Modulating Apolipoprotein (A) Expression
In force
 · Low confidence
Ionis Pharmaceuticals, Inc.In forceLow confidence
US 11,859,180Antisense Oligonucleotide Compositions
In force
 · High confidence
Ionis Pharmaceuticals, Inc.In forceHigh confidence
US 9,885,045Methods and Compositions for Modulating Apolipoprotein (A) Expression
In force
 · High confidence
Ionis Pharmaceuticals, Inc.In forceHigh confidence
US 10,472,629Methods and Compositions for Modlating Apolipoprotein (A) Expression
In force
 · High confidence
Ionis Pharmaceuticals, Inc.In forceHigh confidence
US 11,634,711Methods and Compositions for Modulating Apolipoprotein (A) Expression
In force
 · Low confidence
Ionis Pharmaceuticals, Inc.In forceLow confidence
Application 14/401,761Antisense Oligonucleotide Compositions
Abandoned
Abandoned Oct 18, 2016
Ionis Pharmaceuticals, Inc.AbandonedAbandoned Oct 18, 2016
Application 14/403,557Methods and Compositions for Modulating Apolipoprotein (A) Expression
Abandoned
Abandoned Nov 3, 2016
Ionis Pharmaceuticals, Inc.AbandonedAbandoned Nov 3, 2016
5 more records in this group · Pro
10 of 15 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 15.
Upgrade to Pro
8 of these are in force and held by Ionis Pharmaceuticals, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited